Search results
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 2 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 5 days agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...
Markets News, June 3, 2024: Nasdaq Ticks Higher; Oil, Treasury Yields Tumble
Investopedia· 2 days agoU.S. stocks were mixed Monday, with weak manufacturing and construction data, as well as falling oil...
Roblox Stock Faces Death Cross As Mixed Earnings, Downgraded Outlook Signal Trouble Ahead - Roblox...
Benzinga· 7 days agoRoth MKM's Eric Handler reduced the price target for Roblox from $55 to $35 while the technical...
3 Sorry Pharma Stocks to Sell in May While You Still Can
InvestorPlace via Yahoo Finance· 7 days agoThere are some pharma stocks to sell in May this year. These companies have been grappling with...
Company News for June 4, 2024
Zacks via Yahoo Finance· 23 hours agoShares of Merck MRK increased 2.3% after the company and its partner, Moderna, Inc. MRNA, announced encouraging results from a trial of two of their...
First Solar Is S&P 500’s Best Performer in May. A Tech Stock Did the Worst.
Barrons.com· 5 days agoThe analysts wrote in a research note that there is a direct...jumped 19% that day. Other top...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoBiotech stock hit a two-year high in February, but have trended lower in the months since despite a...
S&P 500 Spikes in Final 20 Minutes of US Trading: Markets Wrap
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- A renewed bout of volatility gripped US stocks in the final stretch of May, with dip...
3 Sorry Biotech Stocks to Sell in May While You Still Can
InvestorPlace· 5 days agoMorgan Stanley recently released its bullish take on the biotech space, driven by anticipated...